Published in Cardiovascular Business Week, March 14th, 2006
Fiscal 2005 sales were $37 million, a decrease of 10% over sales of $41 million reported for fiscal year 2004.
Highlights include the company's first quarterly sequential revenue growth in 2005, third consecutive quarter of positive operating cash flow,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.